HKD 0.35
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 421.5 Million | -3.06 Billion | 2.76 Billion | -2.31 Billion | -1.76 Billion | -1.65 Billion |
Net Income | 123.56 Million | -1.02 Billion | 1.06 Billion | 808.41 Million | 2.26 Billion | 3.46 Billion |
Depreciation & Amortization | 30.37 Million | 46 Million | 55.26 Million | 39.1 Million | 24.76 Million | 8.26 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 844.78 Million | -1.7 Billion | 3.54 Billion | -2.01 Billion | -1.91 Billion | -2.76 Billion |
Other non-cash items | 293.03 Million | -380.63 Million | -1.9 Billion | -1.14 Billion | -2.13 Billion | -2.36 Billion |
Investing Cash Flow | 1.3 Billion | -481.95 Million | -587.63 Million | 230.67 Million | 563.28 Million | 86.54 Million |
Investments in PPE | -56.39 Million | -5.9 Million | -7.49 Million | -43.83 Million | -13.4 Million | -16.21 Million |
Acquisitions | -385 Thousand | 80 Thousand | 1.21 Billion | -11.15 Million | 552.13 Million | -5.68 Million |
Investment purchases | -45.84 Million | -5.63 Million | -300.52 Million | -1.88 Billion | -781.42 Million | -836.73 Million |
Sales/Maturities of investments | 214.44 Million | 52.03 Million | 1.82 Billion | 724.81 Million | 1.03 Billion | - |
Other Investing Activities | 1.35 Billion | -522.52 Million | -3.31 Billion | 1.45 Billion | -231.45 Million | 108.44 Million |
Financing Cash Flow | -5.9 Billion | 1.19 Billion | 537.45 Million | 6.47 Billion | 1.43 Billion | -453.27 Million |
Debt repayment | -989.02 Million | -1 Billion | -3.28 Billion | -8.03 Billion | -2.28 Billion | -3.91 Billion |
Dividends payments | - | -66.93 Million | -66.93 Million | -267.75 Million | -267.75 Million | -200.73 Million |
Common Stock Repurchased | - | -2.23 Billion | -1.56 Billion | - | - | 3.45 Billion |
Common Stock Issuance | - | 2.23 Billion | 1.56 Billion | - | - | 846 Thousand |
Other Financing Activities | -3.7 Billion | 2.27 Billion | 3.89 Billion | 14.77 Billion | 3.98 Billion | 209.1 Million |
Accounts receivables | -46.72 Million | 64.04 Million | -2.03 Billion | -3.86 Billion | -605.89 Million | -687.93 Million |
Accounts payables | -644.8 Million | -1.77 Billion | 3.63 Billion | -3.85 Billion | 800.24 Million | 2.8 Billion |
Inventory | 6.46 Billion | 3.06 Billion | 45.14 Million | -532.59 Million | -703.55 Million | -1.39 Billion |
Other working capital | 671.2 Million | -3.06 Billion | 1.9 Billion | 6.23 Billion | -1.4 Billion | -1.36 Billion |
Cash at beginning of period | 7.7 Billion | 10.95 Billion | 8.23 Billion | 3.85 Billion | 3.6 Billion | 5.63 Billion |
Cash at end of period | 3.41 Billion | 7.7 Billion | 10.95 Billion | 8.23 Billion | 3.85 Billion | 3.6 Billion |
Capital Expenditure | -56.39 Million | -5.9 Million | -7.49 Million | -43.83 Million | -13.4 Million | -16.21 Million |
Effect of forex changes on cash | -106.83 Million | -906.07 Million | - | - | - | - |
Net cash flow / Change in cash | -4.29 Billion | -3.25 Billion | 2.71 Billion | 4.38 Billion | 242.32 Million | -2.02 Billion |
Free Cash Flow | 365.1 Million | -3.07 Billion | 2.76 Billion | -2.35 Billion | -1.77 Billion | -1.67 Billion |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -522.24 Million | -522.24 Million | -563.6 Million | 123.56 Million | -563.6 Million | 111.69 Million |
Depreciation & Amortization | 4.65 Million | 4.65 Million | 7.45 Million | 30.37 Million | 7.45 Million | 15.45 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | 3.54 Billion | 844.78 Million | 3.54 Billion | - |
Other non-cash items | 1 Billion | 1 Billion | -3 Billion | 293.03 Million | -3 Billion | 457.98 Million |
Investing Cash Flow | 35.01 Million | 35.01 Million | 649.01 Million | 1.3 Billion | 649.01 Million | -89.93 Million |
Investments in PPE | -12.12 Million | -12.12 Million | -19.22 Million | -56.39 Million | -19.22 Million | -17.94 Million |
Acquisitions | -124.86 Million | - | -87.9 Million | -385 Thousand | - | 1.49 Million |
Investment purchases | -43.87 Million | - | -27.72 Million | -45.84 Million | - | -18.11 Million |
Sales/Maturities of investments | 30.04 Million | - | 64.67 Million | 214.44 Million | - | 149.76 Million |
Other Investing Activities | 47.14 Million | 47.14 Million | 668.24 Million | 1.35 Billion | 668.24 Million | -205.12 Million |
Financing Cash Flow | -738.69 Million | -738.69 Million | -2.5 Billion | -5.9 Billion | -2.5 Billion | -898.25 Million |
Debt repayment | -1.18 Billion | - | -2.52 Billion | -989.02 Million | - | -1.53 Billion |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -738.69 Million | -738.69 Million | -2.5 Billion | -3.7 Billion | -2.5 Billion | -2.42 Billion |
Accounts receivables | - | - | -23.36 Million | -46.72 Million | -23.36 Million | - |
Accounts payables | - | - | - | -644.8 Million | - | - |
Inventory | - | - | 3.23 Billion | 6.46 Billion | 3.23 Billion | - |
Other working capital | - | - | 335.6 Million | 671.2 Million | 335.6 Million | - |
Cash at beginning of period | 3.51 Billion | - | 7.35 Billion | 7.7 Billion | - | 8.42 Billion |
Cash at end of period | 2.99 Billion | -225.75 Million | 3.51 Billion | 3.41 Billion | -1.81 Billion | 7.35 Billion |
Capital Expenditure | -12.12 Million | -12.12 Million | -19.22 Million | -56.39 Million | -19.22 Million | -17.94 Million |
Effect of forex changes on cash | -7.71 Million | -7.71 Million | 63.49 Million | -106.83 Million | 63.49 Million | -116.91 Million |
Net cash flow / Change in cash | -514.51 Million | -225.75 Million | -3.83 Billion | -4.29 Billion | -1.81 Billion | -1.07 Billion |
Free Cash Flow | 473.51 Million | 473.51 Million | -38.04 Million | 365.1 Million | -38.04 Million | 536.27 Million |
002938
TRN
PDRX
ACA
DYSL
MDV